Hong Kong Stock Movement | SINOPHARM (01099) Rises Over 3% Ahead of Q3 Results; China National Medicines Reports 13.1% YoY Profit Growth

Stock News

10/22

According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on October 24 to discuss and approve the unaudited quarterly results for the nine months ending September 30, 2025, for the company and its subsidiaries. Its subsidiary, China National Medicines Corporation Ltd. achieved a revenue of RMB 13.747 billion for the third quarter, a year-on-year increase of 3.58%, while the net profit attributable to shareholders of the listed company was RMB 544 million, marking a 13.10% year-on-year growth.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1149455012"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149455012\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149455012?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 10:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149455012","market":"sg","top_or_hot":-1,"title":"Hong Kong Stock Movement | SINOPHARM (01099) Rises Over 3% Ahead of Q3 Results; China National Medicines Reports 13.1% YoY Profit Growth","media":"Stock News","content":"<p>According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on October 24 to discuss and approve the unaudited quarterly results for the nine months ending September 30, 2025, for the company and its subsidiaries. Its subsidiary, China National Medicines Corporation Ltd. achieved a revenue of RMB 13.747 billion for the third quarter, a year-on-year increase of 3.58%, while the net profit attributable to shareholders of the listed company was RMB 544 million, marking a 13.10% year-on-year growth.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Movement | SINOPHARM (01099) Rises Over 3% Ahead of Q3 Results; China National Medicines Reports 13.1% YoY Profit Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Movement | SINOPHARM (01099) Rises Over 3% Ahead of Q3 Results; China National Medicines Reports 13.1% YoY Profit Growth\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2025-10-22 10:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on October 24 to discuss and approve the unaudited quarterly results for the nine months ending September 30, 2025, for the company and its subsidiaries. Its subsidiary, China National Medicines Corporation Ltd. achieved a revenue of RMB 13.747 billion for the third quarter, a year-on-year increase of 3.58%, while the net profit attributable to shareholders of the listed company was RMB 544 million, marking a 13.10% year-on-year growth.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600511","symbol_name":"國藥股份","start_time":0,"source_url":"","article_id":"1149455012","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149455012","pubTimestamp":1761098415,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600511":"国药股份","BK1197":"保健护理产品经销商","BK0010":"央企","BK0185":"二线龙头","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD","BK1515":"抗疫概念","BK0188":"融资融券","BK0028":"国家队","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","BK1500":"做空集合股","BK0175":"白马股","BK0012":"证金概念","BK0082":"国资改革","BK0250":"批发","01099":"国药控股","BK0097":"医药电商"},"translate_title":"港股动向|国药控股(01099)Q3业绩前升超3%；中国医药利润同比增长13.1%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600511":1,"01099":1},"content_text":"According to reports, SINOPHARM (01099) is up over 3%, currently rising 3.26% to HKD 19.33, with a trading volume of HKD 71.91 million. On the news front, SINOPHARM will hold a board meeting on October 24 to discuss and approve the unaudited quarterly results for the nine months ending September 30, 2025, for the company and its subsidiaries. Its subsidiary, China National Medicines Corporation Ltd. achieved a revenue of RMB 13.747 billion for the third quarter, a year-on-year increase of 3.58%, while the net profit attributable to shareholders of the listed company was RMB 544 million, marking a 13.10% year-on-year growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}